Keep your social presence active across platforms with Feedsta, described by its makers as an AI social media manager that can create, schedule, and analyze posts, so brands may stay visible where customers research their business.
OpenAI launched GPT-Rosalind on April 16, 2026, its first dedicated life sciences AI model, named after Rosalind Franklin, the British chemist whose X-ray crystallography work revealed the double-helix structure of DNA. The model is fine-tuned for biology research workflows and is available in limited preview through OpenAI’s trusted access program, with launch partners including Amgen, Moderna, the Allen Institute, and Thermo Fisher Scientific.
What does GPT-Rosalind do?
Unlike general-purpose models, GPT-Rosalind is fine-tuned specifically for biology research workflows. It can:
- Synthesize evidence across massive volumes of scientific literature and databases
- Generate biological hypotheses from existing data
- Plan multi-step experiments
- Identify biological pathways and analyze regulatory mechanisms
- Suggest and prioritize drug targets
- Connect genotype to phenotype through known pathways
- Infer structural and functional protein properties
- Query major public biological databases and read the latest papers in real time
What problem is it solving?
Biology research has a data problem. Decades of genome sequencing and protein biochemistry have generated more data than human researchers can synthesize. Scientists routinely spend months manually cross-referencing literature, specialized databases, experimental data, and evolving hypotheses, work that is time-intensive and difficult to scale.
Drug development timelines reflect this bottleneck: it currently takes up to 15 years from target discovery to regulatory approval. GPT-Rosalind is designed to compress that timeline by handling the synthesis and hypothesis-generation layers at machine speed.
How does GPT-Rosalind perform?
OpenAI published benchmark results at launch:
- BixBench (bioinformatics and data analysis): 0.751 pass rate, the highest among models with published results
- LABBench2 (literature retrieval, protocol design, research tasks): outperformed GPT-5.4 on 6 of 11 tasks
- Dyno Therapeutics partnership (RNA sequence-to-function prediction): best-of-10 submissions ranked above the 95th percentile of human experts on prediction; ~84th percentile on sequence generation
How is it different from AlphaFold?
Google DeepMind’s AlphaFold won the Nobel Prize in Chemistry in 2024 for protein structure prediction. GPT-Rosalind is broader in scope, it’s not a specialized structure predictor but a reasoning model that can navigate the full research workflow: reading, hypothesizing, planning, and connecting biological systems.
Who has access?
GPT-Rosalind launched in limited research preview, available in ChatGPT, Codex, and the API for qualified customers via OpenAI’s trusted access program. Launch partners include Amgen, Moderna, the Allen Institute, and Thermo Fisher Scientific.
A free Life Sciences Codex plugin, connecting to 50+ scientific tools and data sources, launched alongside it.
Why does this matter beyond biology?
GPT-Rosalind suggests that AI is shifting from general-purpose assistance toward domain-specific expert systems intended to perform specialized tasks at or above human expert levels. Other industries will likely see purpose-built models.
The question for businesses paying attention to AI is no longer whether AI can help in their field, but whether a competitor will adopt a purpose-built model first.
GPT-Rosalind launched April 16, 2026. Access is currently limited to qualified research partners.
Wondering if your own business shows up in ChatGPT, Gemini, or Perplexity? Curious how your business might show up in ChatGPT, Gemini, or Perplexity? A BizScoreAI scan can offer an AI Visibility Score and a prioritized list of possible fixes.
FAQ
What is GPT-Rosalind?
GPT-Rosalind is OpenAI’s first dedicated life sciences AI model, announced on April 16, 2026, and named after Rosalind Franklin, the British chemist whose X-ray crystallography work revealed the double-helix structure of DNA. It is fine-tuned for biology research workflows including literature synthesis, hypothesis generation, experiment planning, and drug target prioritization.
Who can use GPT-Rosalind?
GPT-Rosalind launched in limited research preview, available in ChatGPT, Codex, and the API for qualified customers through OpenAI’s trusted access program. Launch partners include Amgen, Moderna, the Allen Institute, and Thermo Fisher Scientific, alongside a free Life Sciences Codex plugin connecting to 50+ scientific tools and data sources.
How does GPT-Rosalind compare to AlphaFold?
AlphaFold won the 2024 Nobel Prize in Chemistry for protein structure prediction. GPT-Rosalind is broader in scope, functioning as a reasoning model across the full research workflow of reading, hypothesizing, planning, and connecting biological systems, rather than as a specialized structure predictor.
Related coverage
Want help with this in Myrtle Beach or Long Island? Talk to us.
NewSunSEO
Grow in Google and AI Search
AI-SEO, local search, paid ads and websites from one team, with offices on Long Island and in Myrtle Beach.
- AI-SEO
- Local AI-SEO
- AI Consulting
- PPC
- Web Design
- Web Development
- Long Island Office(631) 320-1700
- Myrtle Beach Office(843) 492-7131
Request a Free Proposal
Tell us about your business and where you want to grow.
We will reply by email to talk through your goals and what a proposal would include.
We use your details only to reply to you and send what you asked for. See our Privacy Policy.
